| Record Information |
|---|
| Version | 2.0 |
|---|
| Created at | 2022-05-11 16:52:50 UTC |
|---|
| Updated at | 2022-05-11 16:52:50 UTC |
|---|
| NP-MRD ID | NP0087552 |
|---|
| Secondary Accession Numbers | None |
|---|
| Natural Product Identification |
|---|
| Common Name | Lacto-N-biose I |
|---|
| Description | Lacto-N-biose I, also known as gal(b1-3)a-glcnac, belongs to the class of organic compounds known as acylaminosugars. These are organic compounds containing a sugar linked to a chain through N-acyl group. Lacto-N-biose I is an extremely weak basic (essentially neutral) compound (based on its pKa). Lacto-N-biose I was first documented in 2004 (PMID: 14993226). A beta-D-Galp-(1->3)-D-GlcpNAc in which the N-acetylaminoglucose moiety has alpha configuration (PMID: 19420691) (PMID: 23270920) (PMID: 24065834) (PMID: 24936348). |
|---|
| Structure | CC(=O)N[C@H]1[C@@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O InChI=1S/C14H25NO11/c1-4(18)15-7-12(9(20)6(3-17)24-13(7)23)26-14-11(22)10(21)8(19)5(2-16)25-14/h5-14,16-17,19-23H,2-3H2,1H3,(H,15,18)/t5-,6-,7-,8+,9-,10+,11-,12-,13+,14+/m1/s1 |
|---|
| Synonyms | | Value | Source |
|---|
| Gal(b1-3)a-glcnac | ChEBI | | WURCS=2.0/2,2,1/[a2122h-1a_1-5_2*ncc/3=o][a2112h-1b_1-5]/1-2/a3-b1 | ChEBI | | 2-Acetamido-2-deoxy-3-O-b-D-galactopyranosyl-D-glucose | HMDB | | 2-Acetamido-2-deoxy-3-O-beta-D-galactopyranosyl-D-glucopyranose | HMDB | | 2-Acetamido-2-deoxy-3-O-beta-D-galactopyranosyl-D-glucose | HMDB | | 2-Acetamido-2-deoxy-3-O-beta-delta-galactopyranosyl-delta-glucopyranose | HMDB | | 2-Acetamido-2-deoxy-3-O-beta-delta-galactopyranosyl-delta-glucose | HMDB | | beta-D-Gal-(1->3)-D-glcnac | HMDB | | beta-D-Galactopyranosyl-(1->3)-N-acetyl-D-glucosamine | HMDB | | beta-delta-Gal-(1->3)-delta-glcnac | HMDB | | beta-delta-Galactopyranosyl-(1->3)-N-acetyl-delta-glucosamine | HMDB | | Gal(beta1-3)glcnac | HMDB | | Lacto-N-biose | HMDB | | O-beta-D-Galactopyranosyl-(1->3)-N-acetylglucosamine | HMDB | | O-beta-delta-Galactopyranosyl-(1->3)-N-acetylglucosamine | HMDB | | Gal-1,3-glcnac | HMDB | | Galactosyl-1,3-N-acetylglucosamine | HMDB | | N-[(2S,3R,4R,5S,6R)-2,5-Dihydroxy-6-(hydroxymethyl)-4-{[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-3-yl]ethanimidate | HMDB | | Lacto-N-biose I | MeSH |
|
|---|
| Chemical Formula | C14H25NO11 |
|---|
| Average Mass | 383.3484 Da |
|---|
| Monoisotopic Mass | 383.14276 Da |
|---|
| IUPAC Name | N-[(2S,3R,4R,5S,6R)-2,5-dihydroxy-6-(hydroxymethyl)-4-{[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-3-yl]acetamide |
|---|
| Traditional Name | N-[(2S,3R,4R,5S,6R)-2,5-dihydroxy-6-(hydroxymethyl)-4-{[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-3-yl]acetamide |
|---|
| CAS Registry Number | Not Available |
|---|
| SMILES | CC(=O)N[C@H]1[C@@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O |
|---|
| InChI Identifier | InChI=1S/C14H25NO11/c1-4(18)15-7-12(9(20)6(3-17)24-13(7)23)26-14-11(22)10(21)8(19)5(2-16)25-14/h5-14,16-17,19-23H,2-3H2,1H3,(H,15,18)/t5-,6-,7-,8+,9-,10+,11-,12-,13+,14+/m1/s1 |
|---|
| InChI Key | HMQPEDMEOBLSQB-RCBHQUQDSA-N |
|---|
| Experimental Spectra |
|---|
|
| Not Available | | Predicted Spectra |
|---|
|
| | Spectrum Type | Description | Depositor ID | Depositor Organization | Depositor | Deposition Date | View |
|---|
| 1D NMR | 13C NMR Spectrum (1D, 25 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 100 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 252 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 1000 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 50 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 200 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 75 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 300 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 101 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 400 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 126 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 500 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 151 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 600 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 176 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 700 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 201 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 800 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 226 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 900 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum |
| | Chemical Shift Submissions |
|---|
|
| Not Available | | Species |
|---|
| Species of Origin | |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as acylaminosugars. These are organic compounds containing a sugar linked to a chain through N-acyl group. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Organic oxygen compounds |
|---|
| Class | Organooxygen compounds |
|---|
| Sub Class | Carbohydrates and carbohydrate conjugates |
|---|
| Direct Parent | Acylaminosugars |
|---|
| Alternative Parents | |
|---|
| Substituents | - Acylaminosugar
- N-acyl-alpha-hexosamine
- Disaccharide
- Glycosyl compound
- O-glycosyl compound
- Oxane
- Acetamide
- Carboxamide group
- Hemiacetal
- Secondary carboxylic acid amide
- Secondary alcohol
- Acetal
- Carboxylic acid derivative
- Oxacycle
- Organoheterocyclic compound
- Polyol
- Hydrocarbon derivative
- Organic oxide
- Organic nitrogen compound
- Organopnictogen compound
- Alcohol
- Primary alcohol
- Organonitrogen compound
- Carbonyl group
- Aliphatic heteromonocyclic compound
|
|---|
| Molecular Framework | Aliphatic heteromonocyclic compounds |
|---|
| External Descriptors | Not Available |
|---|
| Physical Properties |
|---|
| State | Not Available |
|---|
| Experimental Properties | | Property | Value | Reference |
|---|
| Melting Point | Not Available | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | Not Available | Not Available | | LogP | Not Available | Not Available |
|
|---|
| Predicted Properties | |
|---|
| General References | - Kakuda S, Shiba T, Ishiguro M, Tagawa H, Oka S, Kajihara Y, Kawasaki T, Wakatsuki S, Kato R: Structural basis for acceptor substrate recognition of a human glucuronyltransferase, GlcAT-P, an enzyme critical in the biosynthesis of the carbohydrate epitope HNK-1. J Biol Chem. 2004 May 21;279(21):22693-703. doi: 10.1074/jbc.M400622200. Epub 2004 Mar 1. [PubMed:14993226 ]
- Kiyohara M, Tachizawa A, Nishimoto M, Kitaoka M, Ashida H, Yamamoto K: Prebiotic effect of lacto-N-biose I on bifidobacterial growth. Biosci Biotechnol Biochem. 2009 May;73(5):1175-9. doi: 10.1271/bbb.80697. Epub 2009 May 7. [PubMed:19420691 ]
- Satoh T, Odamaki T, Namura M, Shimizu T, Iwatsuki K, Nishimoto M, Kitaoka M, Xiao JZ: In vitro comparative evaluation of the impact of lacto-N-biose I, a major building block of human milk oligosaccharides, on the fecal microbiota of infants. Anaerobe. 2013 Feb;19:50-7. doi: 10.1016/j.anaerobe.2012.12.007. Epub 2012 Dec 25. [PubMed:23270920 ]
- Koyama Y, Hidaka M, Nishimoto M, Kitaoka M: Directed evolution to enhance thermostability of galacto-N-biose/lacto-N-biose I phosphorylase. Protein Eng Des Sel. 2013 Nov;26(11):755-61. doi: 10.1093/protein/gzt049. Epub 2013 Sep 24. [PubMed:24065834 ]
- Goto M, Takano-Ishikawa Y, Nishimoto M, Kitaoka M: Effect of Lacto-N-biose I on the Antigen-specific Immune Responses of Splenocytes. Biosci Microbiota Food Health. 2012;31(2):47-50. doi: 10.12938/bmfh.31.47. Epub 2012 Apr 20. [PubMed:24936348 ]
|
|---|